Ignacio Zarante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ignacio Zarante has a total of 576 co-authors. Here are the top co-authors by number of shared publications:
- Paula Hurtado-Villa
Department of Basic Sciences of Health, School of Health Pontificia Universidad Javeriana Cali Colombia
14 shared publications - Karen Sarmiento
Department of Physiologic Science, Faculty of Medicine Pontificia Universidad Javeriana Bogotá Colombia
10 shared publications - Nicolas Fernandez
Division of Urology, Seattle Children’s Hospital – University of Washington, Seattle, USA
9 shared publications - Fernando Suárez-Obando
Pontificia Universidad Javeriana
8 shared publications - Gloria Gracia
Secretaría Distrital de Salud de Bogotá, Colombia
6 shared publications Elena Szabova
Slovak Teratologic Information Centre (FPH) Slovak Medical University Bratislava Slovak Republic
5 shared publications
Latest Publications
- Open Access
- 15 August 2025
- Published by Springer Nature in Journal of Community Genetics
- Vol. 16 (6) , 705-719
Strengthening Medical Genetics and Genomic Medicine in Colombia: Progress, Challenges, and Strategic Opportunities
Colombia, an upper-middle-income country with over 52 million inhabitants, has made significant progress in consolidating medical genetics as a clinical specialty, with a growing presence in healthcare system, public health and academia. The development of specialized training programs, the establishment of a professional association, and the inclusion of genetic tests and treatments for rare diseases (RDs) within the health system have been key achievements. Birth defects (BD) remain one of the leading causes of infant morbidity and mortality, and alongside RDs, are recognized as public health priorities. Among regulatory milestones, the Newborn Screening (NBS) Law has strengthened early diagnosis efforts. Nevertheless, operational challenges persist, particularly in the nationwide implementation of genetic services, which remain concentrated in urban centers, creating significant gaps in rural areas. While technologies such as next-generation sequencing (NGS) are increasingly available in the private sector, a persistent fragmentation between molecular diagnosis and clinical care limits their impact. Furthermore, interoperability with health information systems is limited, and the country’s low density of medical geneticists restricts service availability. The Colombian experience underscores the value of institutional coordination, investment in diagnostic infrastructure, and the active role of patient organizations. Despite existing challenges, regional cooperation within Latin America emerges as a strategic opportunity to strengthen medical genetics and expand access for populations affected by RDs and complex genetic conditions.
- 15 August 2025
- Published by Springer Nature in Journal of Community Genetics
- Vol. 16 (6) , 705-719
Open AccessStrengthening Medical Genetics and Genomic Medicine in Colombia: Progress, Challenges, and Strategic Opportunities
Colombia, an upper-middle-income country with over 52 million inhabitants, has made significant progress in consolidating medical genetics as a clinical specialty, with a growing presence in healthcare system, public health and academia. The development of specialized training programs, the establishment of a professional association, and the inclusion of genetic tests and treatments for rare diseases (RDs) within the health system have been key achievements. Birth defects (BD) remain one of the leading causes of infant morbidity and mortality, and alongside RDs, are recognized as public health priorities. Among regulatory milestones, the Newborn Screening (NBS) Law has strengthened early diagnosis efforts. Nevertheless, operational challenges persist, particularly in the nationwide implementation of genetic services, which remain concentrated in urban centers, creating significant gaps in rural areas. While technologies such as next-generation sequencing (NGS) are increasingly available in the private sector, a persistent fragmentation between molecular diagnosis and clinical care limits their impact. Furthermore, interoperability with health information systems is limited, and the country’s low density of medical geneticists restricts service availability. The Colombian experience underscores the value of institutional coordination, investment in diagnostic infrastructure, and the active role of patient organizations. Despite existing challenges, regional cooperation within Latin America emerges as a strategic opportunity to strengthen medical genetics and expand access for populations affected by RDs and complex genetic conditions.
- 4 July 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Musculoskeletal Research
- Vol. 28 (04)
ARTHROGRYPOSIS MULTIPLEX CONGENITA: A CASE-CONTROL STUDY ANALYZING RISK FACTORS FOR NEWBORN PRESENTATION IN BOGOTá AND CALI, COLOMBIA
Background: Arthrogryposis Multiplex Congenita (AMC) is a rare musculoskeletal birth defect, our objective is to conduct an epidemiological characterization of the prevalence and risk factors associated with the presentation of AMC in newborns. Methods: A population-based case-control study was performed with the data from the Program for the Prevention and Surveillance of Birth Defects and Rare Diseases of Bogotá and Cali (PREVERDEC) from January 2002 to March 2020. Including 29 cases of AMC and 126 controls. Prevalence was calculated per 10,000 Live Births (LB) with a 95% confidence interval. Demographic factors were analyzed using Student’s [ ]-test, and risk factors for AMC were assessed through univariate regression. Results: The prevalence of AMC amounted to 0.52 cases per 10,000 LB (95% CI: 0.35–0.75). Increased association for AMC was found in cases with low birth weight (<2,500 g), low gestational age (35 years, male newborns and folic acid consumption. Conclusion: This study explores the prevalence and risk factors of AMC in Bogotá and Cali, Colombia, aiming to mitigate morbidity in susceptible populations. Establishing surveillance systems for congenital abnormalities is crucial for enhancing AMC identification, diagnosis, and early treatment.
- 4 July 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Musculoskeletal Research
- Vol. 28 (04)
ARTHROGRYPOSIS MULTIPLEX CONGENITA: A CASE-CONTROL STUDY ANALYZING RISK FACTORS FOR NEWBORN PRESENTATION IN BOGOTá AND CALI, COLOMBIA
Background: Arthrogryposis Multiplex Congenita (AMC) is a rare musculoskeletal birth defect, our objective is to conduct an epidemiological characterization of the prevalence and risk factors associated with the presentation of AMC in newborns. Methods: A population-based case-control study was performed with the data from the Program for the Prevention and Surveillance of Birth Defects and Rare Diseases of Bogotá and Cali (PREVERDEC) from January 2002 to March 2020. Including 29 cases of AMC and 126 controls. Prevalence was calculated per 10,000 Live Births (LB) with a 95% confidence interval. Demographic factors were analyzed using Student’s [ ]-test, and risk factors for AMC were assessed through univariate regression. Results: The prevalence of AMC amounted to 0.52 cases per 10,000 LB (95% CI: 0.35–0.75). Increased association for AMC was found in cases with low birth weight (<2,500 g), low gestational age (35 years, male newborns and folic acid consumption. Conclusion: This study explores the prevalence and risk factors of AMC in Bogotá and Cali, Colombia, aiming to mitigate morbidity in susceptible populations. Establishing surveillance systems for congenital abnormalities is crucial for enhancing AMC identification, diagnosis, and early treatment.
- 20 December 2024
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 76
Transposition of the great vessels in Bogotá and Cali, Colombia: A current perspective
- 20 December 2024
- Published by Elsevier in Progress in Pediatric Cardiology
- Vol. 76
Transposition of the great vessels in Bogotá and Cali, Colombia: A current perspective
- Open Access
- 6 November 2024
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 19 (1) , 1-14
Pain, quality of life, and integral management in a cohort of patients diagnosed with hypophosphatasia in Colombia
Background: Hypophosphatasia (HPP; OMIM 241510, 241500, and 146300) is a progressive metabolic, genetic disease with wide clinical heterogeneity, ranging from perinatal lethality to mild or moderate localized symptoms. This study aims to analyze the perception of pain, quality of life, and access barriers to healthcare among patients diagnosed with hypophosphatasia in Colombia. In this document we present pain and quality of life results. Methods: This study is an observational cohort of 18 HPP patients registered in the Colombian Association of Patients with Lysosomal Storage Diseases and Other Orphan Diseases (ACOPEL) database. We conducted a descriptive analysis using data from three questionnaires (SF-36, Brief Pain Questionnaire (BPQ), and Hypophosphatasia Impact Patient Survey (HIPS); the latter was translated into Spanish and validated for this study. Results: The most affected features, according to the SF-36 questionnaire, were overall health, vitality, and pain, with a median score above 67%. Patients' perception of their health status (HIPS questionnaire) was favorable, with 38.9% of cases reporting excellent health. On average, results from the BPQ indicated mild to moderate intensity of current pain experienced by patients. Consistency was observed in the reports of either the absence of pain or the presence of mild to moderate intensity when analyzing the results of the three questionnaires. Conclusions: Colombian patients with HPP experience mild to moderate impairment in quality of life and pain that interfere with their daily activities. However, there is wide variability in the results obtained.
- 6 November 2024
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 19 (1) , 1-14
Open AccessPain, quality of life, and integral management in a cohort of patients diagnosed with hypophosphatasia in Colombia
Background: Hypophosphatasia (HPP; OMIM 241510, 241500, and 146300) is a progressive metabolic, genetic disease with wide clinical heterogeneity, ranging from perinatal lethality to mild or moderate localized symptoms. This study aims to analyze the perception of pain, quality of life, and access barriers to healthcare among patients diagnosed with hypophosphatasia in Colombia. In this document we present pain and quality of life results. Methods: This study is an observational cohort of 18 HPP patients registered in the Colombian Association of Patients with Lysosomal Storage Diseases and Other Orphan Diseases (ACOPEL) database. We conducted a descriptive analysis using data from three questionnaires (SF-36, Brief Pain Questionnaire (BPQ), and Hypophosphatasia Impact Patient Survey (HIPS); the latter was translated into Spanish and validated for this study. Results: The most affected features, according to the SF-36 questionnaire, were overall health, vitality, and pain, with a median score above 67%. Patients' perception of their health status (HIPS questionnaire) was favorable, with 38.9% of cases reporting excellent health. On average, results from the BPQ indicated mild to moderate intensity of current pain experienced by patients. Consistency was observed in the reports of either the absence of pain or the presence of mild to moderate intensity when analyzing the results of the three questionnaires. Conclusions: Colombian patients with HPP experience mild to moderate impairment in quality of life and pain that interfere with their daily activities. However, there is wide variability in the results obtained.
- Open Access
- 18 July 2024
- Published by Lepidus Tecnologia in Pediatría
- Vol. 57 (2) , e494
Panorama de la fenilcetonuria en Colombia
Antecedentes: La fenilcetonuria (PKU), es un error innato del metabolismo secundario a un defecto del metabolismo hepático de la fenilalanina. Su acumulación afecta principalmente el sistema nervioso central, generando discapacidad cognitiva y alteración comportamental importante. Tema: El diagnóstico temprano, mediante el cribado neonatal, permite modificar la historia natural de la enfermedad y brindar un adecuado asesoramiento genético. Conclusión: Los autores damos una revisión al estado actual de la patología y el tamizaje neonatal en Colombia, así como los retos en el seguimiento y manejo de estos pacientes diagnosticados temprana o tardíamente.
- 18 July 2024
- Published by Lepidus Tecnologia in Pediatría
- Vol. 57 (2) , e494
Open AccessPanorama de la fenilcetonuria en Colombia
Antecedentes: La fenilcetonuria (PKU), es un error innato del metabolismo secundario a un defecto del metabolismo hepático de la fenilalanina. Su acumulación afecta principalmente el sistema nervioso central, generando discapacidad cognitiva y alteración comportamental importante. Tema: El diagnóstico temprano, mediante el cribado neonatal, permite modificar la historia natural de la enfermedad y brindar un adecuado asesoramiento genético. Conclusión: Los autores damos una revisión al estado actual de la patología y el tamizaje neonatal en Colombia, así como los retos en el seguimiento y manejo de estos pacientes diagnosticados temprana o tardíamente.
- Open Access
- 16 May 2024
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 65 (1)
Moving towards new horizons: the evolution of Universitas Médica
- 16 May 2024
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 65 (1)
Open AccessMoving towards new horizons: the evolution of Universitas Médica
- Open Access
- 16 March 2024
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 44 (1) , 26-34
Fenotipificación y genotipificación en pacientes con enfermedad inflamatoria intestinal en un centro de referencia de Colombia
Introduction: Attempts have been made to identify the genetic factors related to susceptibility to inflammatory bowel disease (IBD), and the current conclusions are in favor of a complex pathology model, without a clear hereditary pattern. Objective: To perform phenotypic and genotypic characterization of patients with IBD in Colombian population and to describe its possible association with predisposition. Materials and methods: case series, 16 patients with IBD according to clinical and pathological criteria, onset of gastrointestinal symptoms after 18 years of age. All had pre-test genetic counseling and family trees of at least three generations were made. Also, genotyping, using a multigene panel that included genes related to IBD and some autoimmune disorders. Finally, a genomic analysis of variants was performed. Results: 9 women and 7 men, with mean age of diagnosis of IBD of 35 years, and gastrointestinal symptoms appearance of 32 years. 11/16 (68.75%) required biological therapy. 10/16 (62.5%) were refractory to standard therapy. 3/16 (18.75%) had positive family history of IBD. 100% cases presented at least one single nucleotide polymorphism related to IBD risk in more than one gene. The genes most related to ulcerative colitis (UC) were CD48, CD6, and TYK2 for UC, and CD6 and ITGAM for Crohn's disease. The most frequent gene was CD6. It was found presence of up to 5 genes in 3/16 (18.75%), 4 in 3/16 (18.75%), and three in 5/16 (31.25%). Conclusion: In IBD there is the presence of genetic variants with associated predisposition, but without confirmed pathogenicity, and whose sum seems to contribute to its pathophysiology. Introducción: Se ha tratado de identificar los factores genéticos relacionados con susceptibilidad para enfermedad inflamatoria intestinal (EII), y los hallazgos actuales se inclinan por un modelo de patología complejo, sin un patrón hereditario claro. Objetivo: Realizar caracterización fenotípica y genotípica de pacientes con EII en población colombiana y describir su posible asociación con predisposición. Materiales y métodos: Serie de casos, 16 pacientes con EII por criterios clínicos y anatomopatológicos, inicio de síntomas gastrointestinales después de los 18 años. Todos tuvieron asesoramiento genético pre-test y se realizaron árboles genealógicos de mínimo tres generaciones. También, genotipificación, por medio de un panel de genes múltiples que incluía genes relacionados con EII y algunos trastornos autoinmunitarios. Finalmente, se realizó análisis genómico de variantes. Resultados: 9 mujeres y 7 hombres, con edad media de diagnóstico de EII 35 años, y 32 años para aparición de síntomas gastrointestinales. 11/16(68,75%) requirieron terapia biológica. 10/16 (62,5%) presentaron refractariedad a terapia estándar. 3/16 (18,75%) tenían antecedentes familiares positivos de EII. 100% casos presentaron al menos un single nucleotide polymorphism relacionado con riesgo de EII en más de un gen. Los genes más relacionados con colitis ulcerosa (CU), fueron CD48, CD6, y TYK2 para CU, y CD6 e ITGAM para la enfermedad de Crohn. El gen más frecuente fue CD6. Se observó en 3/16 (18,75%) presencia de hasta 5 genes, 4 en 3/16 (18,75%), y tres en 5/16 (31,25%). Conclusión: En EII hay presencia de variantes genéticas con predisposición asociada, pero sin patogenicidad confirmada, y cuya sumatoria parece contribuir en su fisiopatología
- 16 March 2024
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 44 (1) , 26-34
Open AccessFenotipificación y genotipificación en pacientes con enfermedad inflamatoria intestinal en un centro de referencia de Colombia
Introduction: Attempts have been made to identify the genetic factors related to susceptibility to inflammatory bowel disease (IBD), and the current conclusions are in favor of a complex pathology model, without a clear hereditary pattern. Objective: To perform phenotypic and genotypic characterization of patients with IBD in Colombian population and to describe its possible association with predisposition. Materials and methods: case series, 16 patients with IBD according to clinical and pathological criteria, onset of gastrointestinal symptoms after 18 years of age. All had pre-test genetic counseling and family trees of at least three generations were made. Also, genotyping, using a multigene panel that included genes related to IBD and some autoimmune disorders. Finally, a genomic analysis of variants was performed. Results: 9 women and 7 men, with mean age of diagnosis of IBD of 35 years, and gastrointestinal symptoms appearance of 32 years. 11/16 (68.75%) required biological therapy. 10/16 (62.5%) were refractory to standard therapy. 3/16 (18.75%) had positive family history of IBD. 100% cases presented at least one single nucleotide polymorphism related to IBD risk in more than one gene. The genes most related to ulcerative colitis (UC) were CD48, CD6, and TYK2 for UC, and CD6 and ITGAM for Crohn's disease. The most frequent gene was CD6. It was found presence of up to 5 genes in 3/16 (18.75%), 4 in 3/16 (18.75%), and three in 5/16 (31.25%). Conclusion: In IBD there is the presence of genetic variants with associated predisposition, but without confirmed pathogenicity, and whose sum seems to contribute to its pathophysiology. Introducción: Se ha tratado de identificar los factores genéticos relacionados con susceptibilidad para enfermedad inflamatoria intestinal (EII), y los hallazgos actuales se inclinan por un modelo de patología complejo, sin un patrón hereditario claro. Objetivo: Realizar caracterización fenotípica y genotípica de pacientes con EII en población colombiana y describir su posible asociación con predisposición. Materiales y métodos: Serie de casos, 16 pacientes con EII por criterios clínicos y anatomopatológicos, inicio de síntomas gastrointestinales después de los 18 años. Todos tuvieron asesoramiento genético pre-test y se realizaron árboles genealógicos de mínimo tres generaciones. También, genotipificación, por medio de un panel de genes múltiples que incluía genes relacionados con EII y algunos trastornos autoinmunitarios. Finalmente, se realizó análisis genómico de variantes. Resultados: 9 mujeres y 7 hombres, con edad media de diagnóstico de EII 35 años, y 32 años para aparición de síntomas gastrointestinales. 11/16(68,75%) requirieron terapia biológica. 10/16 (62,5%) presentaron refractariedad a terapia estándar. 3/16 (18,75%) tenían antecedentes familiares positivos de EII. 100% casos presentaron al menos un single nucleotide polymorphism relacionado con riesgo de EII en más de un gen. Los genes más relacionados con colitis ulcerosa (CU), fueron CD48, CD6, y TYK2 para CU, y CD6 e ITGAM para la enfermedad de Crohn. El gen más frecuente fue CD6. Se observó en 3/16 (18,75%) presencia de hasta 5 genes, 4 en 3/16 (18,75%), y tres en 5/16 (31,25%). Conclusión: En EII hay presencia de variantes genéticas con predisposición asociada, pero sin patogenicidad confirmada, y cuya sumatoria parece contribuir en su fisiopatología
- Top Cited PapersOpen Access
- 11 November 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (D1) , D1333-D1346
The Human Phenotype Ontology in 2024: phenotypes around the world
The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively organizes and defines the phenotypic features of human disease, enabling computational inference and supporting genomic and phenotypic analyses through semantic similarity and machine learning algorithms. The HPO has widespread applications in clinical diagnostics and translational research, including genomic diagnostics, gene-disease discovery, and cohort analytics. In recent years, groups around the world have developed translations of the HPO from English to other languages, and the HPO browser has been internationalized, allowing users to view HPO term labels and in many cases synonyms and definitions in ten languages in addition to English. Since our last report, a total of 2239 new HPO terms and 49235 new HPO annotations were developed, many in collaboration with external groups in the fields of psychiatry, arthrogryposis, immunology and cardiology. The Medical Action Ontology (MAxO) is a new effort to model treatments and other measures taken for clinical management. Finally, the HPO consortium is contributing to efforts to integrate the HPO and the GA4GH Phenopacket Schema into electronic health records (EHRs) with the goal of more standardized and computable integration of rare disease data in EHRs.
- 11 November 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (D1) , D1333-D1346
Top Cited PapersOpen AccessThe Human Phenotype Ontology in 2024: phenotypes around the world
The Human Phenotype Ontology (HPO) is a widely used resource that comprehensively organizes and defines the phenotypic features of human disease, enabling computational inference and supporting genomic and phenotypic analyses through semantic similarity and machine learning algorithms. The HPO has widespread applications in clinical diagnostics and translational research, including genomic diagnostics, gene-disease discovery, and cohort analytics. In recent years, groups around the world have developed translations of the HPO from English to other languages, and the HPO browser has been internationalized, allowing users to view HPO term labels and in many cases synonyms and definitions in ten languages in addition to English. Since our last report, a total of 2239 new HPO terms and 49235 new HPO annotations were developed, many in collaboration with external groups in the fields of psychiatry, arthrogryposis, immunology and cardiology. The Medical Action Ontology (MAxO) is a new effort to model treatments and other measures taken for clinical management. Finally, the HPO consortium is contributing to efforts to integrate the HPO and the GA4GH Phenopacket Schema into electronic health records (EHRs) with the goal of more standardized and computable integration of rare disease data in EHRs.
- Open Access
- 5 November 2023
- Published by Elsevier in Journal of Pediatric Surgery Open
- Vol. 4, 100096
Exploring the prevalence of birth defects of the gastrointestinal tract in newborns: A Six-year analysis in Bogotá, Colombia
- 5 November 2023
- Published by Elsevier in Journal of Pediatric Surgery Open
- Vol. 4, 100096
Open AccessExploring the prevalence of birth defects of the gastrointestinal tract in newborns: A Six-year analysis in Bogotá, Colombia
- Open Access
- 18 August 2023
- Published by Sociedad Chilena de Pediatria in Andes Pediatrica
- Vol. 94 (4) , 536-541
Asociación poco frecuente del complejo OEIS con un defecto diafragmático
El complejo OEIS (onfalocele, extrofia cloacal, ano imperforado y defectos espinales) forma parte de los defectos de pared abdominal. Es una entidad infrecuente, que conlleva alta morbimortalidad y requiere de manejo multidisciplinario. Objetivo: Reportar un caso de asociación poco frecuente entre el complejo OEIS y hernia diafragmática; discutir su patogénesis y posible asociación con otras malformaciones de línea media. Caso Clínico: Neonato pretérmino, con diagnóstico antenatal de onfalocele. Al nacer destacó onfalocele gigante con amnios íntegro que contenía todo el hígado y asas, extrofia vesical con vejiga abierta y orificios uretrales expuestos, útero didelfo, epispadias, no se palparon gónadas, mediante imágenes se logró evidenciar extrusión de los tejidos blandos de pelvis, hernia diafragmática izquierda (Bochdalek), malformaciones óseas, mielomeningocele y mielocistocele. Con dichos hallazgos, se planteó complejo OEIS con presentación simultánea de pentalogía Cantrell o deleción 1p36, en el estudio genético se descartaron cromosomopatías, pero no se pudo completar estudio más específico. Se realizó colostomía, cierre de cloaca y afrontamiento a línea media de placa vesical, con adecuada evolución postoperatoria. Dada estabilidad respiratoria, se difirió corrección quirúrgica de hernia diafragmática. Se dio de alta después de una larga hospitalización, falleciendo por patología respiratoria aguda intercurrente. Conclusiones: Dentro de las asociaciones clínicas del complejo OEIS la hernia diafragmática es infrecuente, lo que podría corresponder a una forma inusual del complejo, debido a presentación simultánea con pentalogía Cantrell o deleción 1p36. A pesar de ser una malformación de presentación esporádica, es importante tener conocimien- to de sus características y variantes.
- 18 August 2023
- Published by Sociedad Chilena de Pediatria in Andes Pediatrica
- Vol. 94 (4) , 536-541
Open AccessAsociación poco frecuente del complejo OEIS con un defecto diafragmático
El complejo OEIS (onfalocele, extrofia cloacal, ano imperforado y defectos espinales) forma parte de los defectos de pared abdominal. Es una entidad infrecuente, que conlleva alta morbimortalidad y requiere de manejo multidisciplinario. Objetivo: Reportar un caso de asociación poco frecuente entre el complejo OEIS y hernia diafragmática; discutir su patogénesis y posible asociación con otras malformaciones de línea media. Caso Clínico: Neonato pretérmino, con diagnóstico antenatal de onfalocele. Al nacer destacó onfalocele gigante con amnios íntegro que contenía todo el hígado y asas, extrofia vesical con vejiga abierta y orificios uretrales expuestos, útero didelfo, epispadias, no se palparon gónadas, mediante imágenes se logró evidenciar extrusión de los tejidos blandos de pelvis, hernia diafragmática izquierda (Bochdalek), malformaciones óseas, mielomeningocele y mielocistocele. Con dichos hallazgos, se planteó complejo OEIS con presentación simultánea de pentalogía Cantrell o deleción 1p36, en el estudio genético se descartaron cromosomopatías, pero no se pudo completar estudio más específico. Se realizó colostomía, cierre de cloaca y afrontamiento a línea media de placa vesical, con adecuada evolución postoperatoria. Dada estabilidad respiratoria, se difirió corrección quirúrgica de hernia diafragmática. Se dio de alta después de una larga hospitalización, falleciendo por patología respiratoria aguda intercurrente. Conclusiones: Dentro de las asociaciones clínicas del complejo OEIS la hernia diafragmática es infrecuente, lo que podría corresponder a una forma inusual del complejo, debido a presentación simultánea con pentalogía Cantrell o deleción 1p36. A pesar de ser una malformación de presentación esporádica, es importante tener conocimien- to de sus características y variantes.